Semax

Semax (10mg) is a research-grade peptide studied in various preclinical and experimental studies for its potential nootropic, neurological, and neuroprotective properties. The peptide is a modified heptapeptide based on the natural tetrapeptide ACTH(4-10), developed to enhance stability and efficacy.

In scientific research, Semax is investigated for its potential effects on attention, memory, mood, stress regulation, and neurochemical processes.

Research Findings:

• Influences neurotransmitters such as dopamine, serotonin, and GABA
• Can induce an increase in BDNF expression, a key factor in learning, recovery, and neuroplasticity
• May improve cognitive performance (focus, memory, information processing) in animal models
• Potentially reduces stress- and anxiety-related markers
• Plays a role in neurological protection, such as improving oxidative stress parameters and inflammatory markers

These findings have been observed exclusively in laboratory and preclinical settings. Semax is not approved for human or therapeutic use.

Research Context:
Semax is used in laboratories and research institutions to study:

• Effects on cognitive functions such as attention, memory, and learning
• Role in neuroplasticity and BDNF regulation
• Possible interactions with stress and anxiety regulation
• Influence on neurological immune and inflammatory processes

The peptide is intended solely for in-vitro research, reference standards, and preclinical purposes. It is not developed or approved for medical, cosmetic, or therapeutic use.

Important Information:

• For laboratory research only
• Not intended for human consumption or injection
• Intended exclusively for research and development purposes
• Buyer is responsible for compliance with local laws and regulations
• Seller is not liable for incorrect or improper use